Nuvalent, Inc. — Director's Dealing 2021

Jul 29, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nuvalent, Inc. (NUVL)
CIK: 0001861560
Period of Report: 2021-07-28

Reporting Person: Turner Christopher Durant (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.89	2031-04-29	Class A Common Stock (341178)		Direct
Stock Option (Right to Buy)	$6.89	2031-04-29	Class A Common Stock (2835)		Direct

Footnotes

F1: The shares underlying this option vest as follows: 25% of the shares vest on March 22, 2022 and the remainder vest over the next three years in equal monthly installments, subject to continued service to the Company through the applicable vesting date.

F2: The shares underlying this option vest as follows: 25% of the shares vest on April 29, 2022 and the remainder vest over the next three years in equal monthly installments, subject to continued service to the Company through the applicable vesting date.